Technology Assisted Treatment of Trichotillomania: Open Trial
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This open-label feasibility trial evaluates the use of the Keen2 awareness bracelet for adults with trichotillomania (hair-pulling disorder). Participants will use the bracelet for eight weeks. During the first four weeks, they will wear the device and log contextual information (such as emotions, location, and activity) after each detected hair-pulling episode. Based on these data, participants will then receive tailored predictive alerts designed to support use of stimulus control, competing responses, and coping strategies. The study will assess usability, adherence, and changes in self-reported hair-pulling severity and awareness.
Sponsor: HabitAware Inc.
You may qualify if…
- ✓ 18 years of age (criterion 1a) with a diagnosis of TTM (criterion 1b)
- ✓ Must reportEnglish as their primary language (criterion 2)
- ✓ Report no current pharmacological or psychosocial intervention targeting TTM symptoms OR a6-week course of either intervention modality without change in frequency,intensity, or dosage (criterion 3)
- ✓ Reliable and consistent access to the internet and/or mobile device permitting the participant to meet withsomeone virtually for 90 min.
- ✓ Must report owning/access to a mobilephone running on Apple's operating system (iOS)
- ✓ Identifies a support person that is able to be contacted is an emergency arises.
- ✓ Agrees to allow the Kent State research team to share home address, mobile number, andalternate number/email with HabitAware, Inc., for purposes of mailing Keen2device and setting up Keen2 system.
You may not qualify if…
- ✕ Current suicidal/homicidal ideation, intent, or plan
- ✕ a diagnosis of another psychiatric condition that may impeded a participant's ability to fully utilize the app (e.g., psychotic disorder, major depressive disorder)
Where it's recruiting
Kent
Source: ClinicalTrials.gov · NCT07224126 · last updated 2025-11-10